MAKERS LABORATORIES LTD.
Latest filings
Next results: Wed, 4 Nov · Financial Results- Board meeting on Nov 4 to consider Q2 FY26-27 results · Results
- Saahil Parikh confirmed as Non-Executive Director via postal ballot · Board & Shareholder Meetings
- Postal Ballot: Saahil Parikh Director Appointment Approved · Board & Shareholder Meetings
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on NSE and BSE, reporting revenue of ₹141 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
MAKERSL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from MAKERS LABORATORIES LTD.'s filed financials and exchange disclosures
What does MAKERS LABORATORIES LTD. do?
MAKERS LABORATORIES LTD. is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol MAKERSL.
Is MAKERS LABORATORIES LTD. profitable?
Yes. Over the trailing twelve months MAKERS LABORATORIES LTD. reported a net profit of ₹7.86 Cr on revenue of ₹141 Cr.
Does MAKERS LABORATORIES LTD. pay a dividend?
Not in the latest reported year — MAKERS LABORATORIES LTD.'s dividend payout for FY26 was nil.
Is MAKERS LABORATORIES LTD. debt-free?
No. It reported borrowings of ₹4.76 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹4.57 Cr after cash. Debt stands at 0.04× equity. That is lower than 64% of its 166 Pharmaceuticals peers.
Is MAKERS LABORATORIES LTD. expensive compared with its peers?
On trailing P/E, MAKERS LABORATORIES LTD. ranks 109 of 158 in Pharmaceuticals — cheaper than 31% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.
When are MAKERS LABORATORIES LTD.'s next results?
Financial Results on Wed, 4 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track MAKERS LABORATORIES LTD.'s announcements?
Every NSE and BSE filing by MAKERS LABORATORIES LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.